Lorraine O'Driscoll
PhD(DCU 1995), MSc(NUI 1991), BSc(NUI 1989), MA jo(Dubl, 2012), FTCD(2012), FRSB(2020), RIA Vice President for Equality, Diversity and InclusionFull Professor of Pharmacology and Biomedicine TCD
Member ScienceElected in 2021
Research Director, Trinity St. James’s Cancer Institute (2020-); Visiting Professor, Dana Farber Cancer Institute, Harvard (2006-); Council Member, TCD (2020-); Irish Cancer Society Research Advisory Committee (2018-); Board of Directors and Chair of Conferences, ISEV (2018-) and ASEV (2023-); RIA Assessment of Candidates for Membership (2021-). Chair, RIA EDI Committee (2023-). On Council 2022-, VP 2023-.